Journal of Clinical Oncology 临床肿瘤· Arnaud Scherpereel·· 2026-10-08AI 评分21
CheckMate 743 勘误:Nivolumab 联合 Ipilimumab 对比化疗一线治疗不可切除胸膜间皮瘤的五年临床结局
Erratum: Five-Year Clinical Outcomes With Nivolumab Plus Ipilimumab Versus Chemotherapy as First-Line Treatment for Unresectable Pleural Mesothelioma in CheckMate 743
AI 导读
Journal of Clinical Oncology 刊登 CheckMate 743 五年临床结局研究的勘误。该勘误涉及 Nivolumab 联合 Ipilimumab 对比化疗一线治疗不可切除胸膜间皮瘤的五年临床结局,刊于第44卷第29期第2878页。
来源:Journal of Clinical Oncology 临床肿瘤 · ascopubs.org